Objectives: The aim of this study was to shorten the 4-h delay between the intravenous administration of gadolinium and MRI acquisition for hydrops evaluation using an optimized 3D-FLAIR sequence in patients with Menière's disease.
Methods: This was a single-center prospective study including 29 patients (58 ears), recruited between November 2020 and February 2021. All patients underwent a 3-T MRI with an optimized 3D-FLAIR sequence without contrast then at 1 h, 2 h, and 4 h after intravenous administration of gadobutrol. The signal intensity ratio was quantitatively assessed with the region of interest method. We also evaluated the volume of endolymphatic structures (saccule, utricle) then the presence of endolymphatic hydrops and blood-labyrinthine barrier impairment at each acquisition time.
Results: For all ears, the signal intensity ratio was significantly non-inferior at 2 h compared to 4 h, with a mean geometric signal intensity ratio at 0.83 (95% CI: 0.76 to 0.90, one-sided p < .001 for non-inferiority at -30% margin). Mean volume equivalence of saccule and utricle between 2 and 4 h was proven at a ± 0.20 standardized deviation equivalence margin. Intra-rater agreements (Cohen's kappa) were all greater than 0.90 for all endolymphatic hydrops location and blood-labyrinthine-barrier impairment between the 2- and 4-h assessments.
Conclusions: We demonstrated that using an optimized 3D-FLAIR sequence we could shorten the acquisition from 4 to 2 h with a high reliability for the diagnosis of endolymphatic hydrops and blood-labyrinthine-barrier impairment.
Clinical Trial Registration: Clinical trial no: 38RC15.173 KEY POINTS: • Magnetic resonance imaging with delayed 3D-FLAIR sequences allows the diagnosis of endolymphatic hydrops in patients with definite Menière's disease. • An optimized 3D-FLAIR sequence with a long TR of 16000 ms and a constant flip angle allows for reducing the delay between intravenous injection of gadobutrol and MRI acquisition from 4 to 2 h to diagnose endolymphatic hydrops. • Reducing this delay between intravenous injection and MRI acquisition could have implications for clinical practice for both patients and imaging departments.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00330-022-08889-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Scanner-specific optimisation of automated lesion segmentation in MS.
Neuroimage Clin
November 2024
MS Center Amsterdam, Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.
Article Synopsis
- - This study aimed to evaluate how reliable automatic lesion segmentation tools are when used on MRI scans of people with multiple sclerosis (pwMS) across different scanners, focusing on their repeatability and accuracy compared to manual segmentation methods.
- - Researchers scanned 30 pwMS using three different MRI machines (two 3.0 T and one 1.5 T) and employed various segmentation techniques, including both automated tools and manual methods, to measure their effectiveness.
- - Results showed that optimizing the segmentation settings for each specific scanner significantly improved accuracy (measured by the Dice similarity coefficient) for one of the software tools (LST) compared to using default settings or a combined approach.
Compressed Sensitivity Encoding Artificial Intelligence Accelerates Brain Metastasis Imaging by Optimizing Image Quality and Reducing Scan Time.
AJNR Am J Neuroradiol
April 2024
From the Department of Radiology (M.W., Y.M., L.L., X.P., Y.W., Y.Q., D.G., D.T.), The First Hospital of Jilin University, Changchun, China.
Background And Purpose: Accelerating the image acquisition speed of MR imaging without compromising the image quality is challenging. This study aimed to evaluate the feasibility of contrast-enhanced (CE) 3D T1WI and CE 3D-FLAIR sequences reconstructed with compressed sensitivity encoding artificial intelligence (CS-AI) for detecting brain metastases (BM) and explore the optimal acceleration factor (AF) for clinical BM imaging.
Materials And Methods: Fifty-one patients with cancer with suspected BM were included.
Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner.
Ann Nucl Med
February 2024
Department of Radiology and Nuclear Medicine, Research Institute for Brain and Blood Vessels-Akita, 6-10 Senshu-kubota-machi, Akita, 010-0874, Japan.
Objective: To verify the visibility of physiological F-fluorodeoxyglucose (F-FDG) uptake in nuclei in and around the brainstem by a whole-body (WB) silicon photomultiplier positron emission tomography (SiPM-PET) scanner with point-spread function (PSF) reconstruction using various iteration numbers.
Methods: Ten healthy subjects (5 men, 5 women; mean age, 56.0 ± 5.
Comparison of an optimized 3D-real IR and a 3D-FLAIR with a constant flip angle in the evaluation of endolymphatic hydrops.
Eur J Radiol
January 2023
Department of Radiology, Zhongshan Hospital, Fudan University, and Shanghai Institute of Medical Imaging, Shanghai 200032, China. Electronic address:
Purpose: To evaluate an optimized 3D-real IR sequence with a longer TR (16,000 ms) based on the modulated flip angle technique in refocused imaging with extended echo train (MATRIX) for the endolymphatic hydrops (EH) after intravenous (IV) single-dose gadolinium (Gd) administration, and compare it with a heavily T2-weighted 3D-FLAIR sequence with a constant flip angle.
Method: The 3D-FLAIR and 3D-real IR sequences were performed in forty patients with definite Meniere's disease (MD) four hours after IV Gd administration. Image qualities of the two sequences were rated and compared.
Optimized 3D-FLAIR sequences to shorten the delay between intravenous administration of gadolinium and MRI acquisition in patients with Menière's disease.
Eur Radiol
October 2022
Department of Neuroradiology, Lariboisière University Hospital, 75010, Paris, France.
Objectives: The aim of this study was to shorten the 4-h delay between the intravenous administration of gadolinium and MRI acquisition for hydrops evaluation using an optimized 3D-FLAIR sequence in patients with Menière's disease.
Methods: This was a single-center prospective study including 29 patients (58 ears), recruited between November 2020 and February 2021. All patients underwent a 3-T MRI with an optimized 3D-FLAIR sequence without contrast then at 1 h, 2 h, and 4 h after intravenous administration of gadobutrol.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!